CoverageForm 410-K10-Q8-K13D13G13F

Luo Ying

CIK 0001959160
Chief Executive OfficerDirector

Filings

4

Latest May 7, 2026

Issuers covered

1

Showing

4 of 4

Page 1

Track record

2 of 2 open-market trades scored (100% price coverage). Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).

HorizonTradesWin rateAvgMedianBestWorst
30 days2100%+21.1%+21.1%+21.8%+20.4%
90 days------
180 days------
365 days------

Issuers

Companies where Luo Ying has filed

TickerIssuerFilingsLast filed
GYREGyre Therapeutics, Inc.4May 7, 2026

All filings

4 Form 4 / 4-A filings, newest first

Sign in to download
Filed Top transactionSharesPriceValue